Internal Medicine

Doç. Dr. Orkide Kutlu

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
Polycystic Ovary SyndromeInsulin Resistance
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Polycystic Ovary Syndrome 3 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Insulin Resistance 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workPolycystic Ovary SyndromeExtracted from 3 publications · Model version —From source
  • Publications74 publicationsORCID, OpenAlex, Europe PMCFrom source
  • ORCID0000-0002-4402-2231ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563381/doktorlarimiz.html#orkide-kutlusaglik.gov.tr

Scientific work

Publications on Polycystic Ovary Syndrome

74 publications
Publications by year Most: 12, in 2013
  1. 2013: 12 publications
  2. 2014: 4 publications
  3. 2015: 7 publications
  4. 2016: 11 publications
  5. 2017: 9 publications
  6. 2018: 4 publications
  7. 2019: 12 publications
  8. 2020: 4 publications
  9. 2021: 3 publications
  10. 2022: 4 publications
  11. 2023: 1 publication
  12. 2024: 0 publications
  13. 2025: 1 publication
  14. 2026: 2 publications

  1. Knowledge of Cardiovascular Disease Risk and Lifestyle Behaviors among Adults with Metabolic Syndrome: A Cross-Sectional Study

    Experimental and Clinical Endocrinology & Diabetes, 2026

    DOI 10.1055/a-2899-6146 PMID 42331031 Source: ORCID

  2. Congenital Insensitivity to Pain with Anhidrosis (CIPA)

    2026

    DOI 10.13140/rg.2.2.20045.60649 Source: OpenAlex

  3. A randomised clinical trial to evaluate a digital therapeutic (TH-001) for improving glycaemic control in adults with prediabetes

    Digital Health, 2025

    DOI 10.1177/20552076251376260 PMID 40949672 Open-access full textSource: OpenAlex

  4. Serum Glypican-3 and Interleukin-6 Levels in COVID-19 Patients

    Turkish Society of Clinical Biochemistry, 2023

    DOI 10.56615/tkbd.2023.02 Open-access full textSource: ORCID

  5. Dahili Hastalarda Özel Beslenme ve Diyet Yönetimi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2182 Source: OpenAlex

  6. A homozygous Y443C variant in the RNPC3 is associated with severe syndromic congenital hypopituitarism and diffuse brain atrophy

    American Journal of Medical Genetics Part A, 2022

    DOI 10.1002/ajmg.a.62888 PMID 35792517 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. DIABETIC PATIENTS' COMPLIANCE WITH TREATMENT DURING COVID-19 PANDEMIC PERIOD

    İstanbul Tıp Fakültesi Dergisi, 2022

    DOI 10.26650/iuitfd.1050290 1 citation (OpenAlex) Open-access full textSource: ORCID

  8. Can the Serum Endocan Level Be Used as a Biomarker to Predict Subclinical Atherosclerosis in Patients with Prediabetes?

    Arquivos brasileiros de cardiologia, 2022

    DOI 10.36660/abc.20210797 PMID 35946756 7 citations (Europe PMC) Open-access full textSource: Europe PMC

  9. Serum galectin-3 levels and vitamin D relationship in heart failure

    Journal of Surgery and Medicine, 2021

    DOI 10.28982/josam.1003992 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Vertebrobasilar Artery Dolicoectasia: A Case Report

    Turkish Journal of Internal Medicine, 2021

    DOI 10.46310/tjim.875949 Open-access full textSource: OpenAlex

View all 74 publications